HAP Trading’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $170K | Buy |
+24,900
| New | +$14.1M | 0.01% | 433 |
|
|
2024
Q1 | – | Sell |
-3,500
| Closed | -$217K | – | 999 |
|
|
2023
Q4 | $217K | Buy |
3,500
+100
| +3% | +$82.3K | 0.03% | 289 |
|
|
2023
Q3 | $276K | Buy |
+3,400
| New | +$2.67M | 0.04% | 268 |
|
|
2022
Q4 | – | Sell |
-6,100
| Closed | -$506K | – | 1810 |
|
|
2022
Q3 | $506K | Sell |
6,100
-100
| -2% | -$62.9K | 0.03% | 355 |
|
|
2022
Q2 | $229K | Buy |
6,200
+2,400
| +63% | +$1.56M | 0.01% | 673 |
|
|
2022
Q1 | $385K | Sell |
3,800
-6,100
| -62% | -$3.86M | 0.02% | 623 |
|
|
2021
Q4 | $643K | Sell |
9,900
-600
| -6% | -$369K | 0.02% | 606 |
|
|
2021
Q3 | $604K | Buy |
10,500
+3,000
| +40% | +$1.86M | 0.02% | 627 |
|
|
2021
Q2 | $462K | Sell |
7,500
-4,200
| -36% | -$2.13M | 0.01% | 674 |
|
|
2021
Q1 | $280K | Sell |
11,700
-4,200
| -26% | -$2.04M | 0.02% | 663 |
|
|
2020
Q4 | $314K | Buy |
15,900
+2,400
| +18% | +$1.3M | 0.01% | 790 |
|
|
2020
Q3 | $699K | Buy |
13,500
+4,800
| +55% | +$2.91M | 0.03% | 331 |
|
|
2020
Q2 | $1.1M | Buy |
8,700
+4,000
| +85% | +$2.27M | 0.06% | 261 |
|
|
2020
Q1 | $329K | Buy |
+4,700
| New | +$1.94M | 0.02% | 421 |
|
|
2018
Q1 | – | Sell |
-10,400
| Closed | -$29K | – | 1154 |
|
|
2017
Q4 | $29K | Buy |
10,400
+200
| +2% | +$81K | ﹤0.01% | 743 |
|
|
2017
Q3 | $595K | Sell |
10,200
-1,600
| -14% | -$761K | 0.03% | 336 |
|
|
2017
Q2 | $1.09M | Sell |
11,800
-6,900
| -37% | -$3.02M | 0.06% | 242 |
|
|
2017
Q1 | $487K | Buy |
18,700
+300
| +2% | +$111K | 0.03% | 345 |
|
|
2016
Q4 | $437K | Buy |
18,400
+1,800
| +11% | +$684K | 0.02% | 369 |
|
|
2016
Q3 | $150K | Buy |
+16,600
| New | +$6.66M | 0.01% | 544 |
|
|
2013
Q4 | – | Sell |
-19,200
| Closed | -$695K | – | 1339 |
|
|
2013
Q3 | $695K | Buy |
+19,200
| New | +$5.05M | 0.02% | 449 |
|
Other funds holding REGN
